Octave Bioscience Revenue and Competitors

Location

#1881

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Octave Bioscience's estimated annual revenue is currently $17.5M per year.(i)
  • Octave Bioscience's estimated revenue per employee is $155,000
  • Octave Bioscience's total funding is $48.5M.

Employee Data

  • Octave Bioscience has 113 Employees.(i)
  • Octave Bioscience grew their employee count by 55% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$1.1M70%N/AN/A
#4
$2.3M15150%N/AN/A
#5
$1.4M90%N/AN/A
#6
$11.5M74-12%N/AN/A
#7
$0.4M27510%$236.7MN/A
#8
$4M51-74%$160MN/A
#9
$2.5M1633%N/AN/A
#10
$3.3M21-12%N/AN/A
Add Company

Octave is developing a comprehensive, first-in-class Care Management Platform. Our team has developed novel measurement tools that feed into structured analytical data models, leading to improved decision-making, better outcomes, and lower costs. We're tackling neurodegenerative diseases -- starting with multiple sclerosis (MS). We believe that to dramatically improve outcomes, we need to improve care management. To improve care management, we first need to improve measurement. That's what Octave is here to do. The challenges for MS are significant, the issues are overwhelming, and the needs are mostly unmet. That's why Octave is creating a comprehensive, measurement-driven care management platform for MS. Finally, stakeholders need better information that is highly actionable. Octave's three layer model of biological, clinical, and economic data combined with sophisticated analytics, contextualization, machine learning and AI provide new insights for physicians, patients, payers, and pharma.

keywords:N/A

$48.5M

Total Funding

113

Number of Employees

$17.5M

Revenue (est)

55%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Octave Bioscience News

2022-03-22 - Octave Bioscience Building Evidence Base for Multiple ...

Octave is developing a product for managing MS that combines protein biomarker measurements along with tools for extracting more actionable data...

2018-07-12 - Octave Bioscience Grabs $14M for Care Management Platform Focused on Neurodegenerative Diseases

Octave Bioscience lands $14M to bring expertise in chronic neurodegenerative markets and molecular Insights for improved care. Octave Bioscience, a Menlo Park, CA-based developer of a fully integrated care management platform delivering powerful insights for patients with neurodegenerative dise ...

2018-07-12 - Octave Bioscience Secures $14M in Series A Financing

Octave Bioscience, a Menlo Park, CA-based developer of a fully integrated care management solution delivering insights for patients with neurodegenerative diseases, completed its $14m Series A funding. The round was led by BCBS Venture Partners with participation from Echo Health Ventures (a st ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$25.1M11416%N/A
#2
$25.9M11412%N/A
#3
$21.4M11963%N/A
#4
$18.6M1200%$201.3M
#5
$15M121-5%N/A